Insilico Medicine
#insilicomeds, #drugdiscovery, #ai, #oncology, #RL, #DL #aging, #longevity #biologics #LLMS #AIDD
288 employees · est. 2014 · Boston, United States
Insilico Medicine is the older company (2016 vs 2014); Insilico Medicine is the larger of the two.
Side-by-Side Comparison
| Metric | iktos | Insilico Medicine |
|---|---|---|
| Founded | ||
| Founded | 2016 | 2014 older |
| Headquarters | ||
| Headquarters | Paris, France | Boston, United States |
| Employees | ||
| Employees | 85 | 288 larger |
| Industry | ||
| Industry | AI, Biotechnology, Health Care | AI, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series A | IPO |
| Total Funding | ||
| Total Funding | $18.90M | $764.50M |
| Funding Rounds | ||
| Funding Rounds | 7 | 13 |
| Services | ||
| Services | Generative AI Platform (Makya), AI-Driven Retrosynthesis (Spaya), Automated Drug Development Pipeline, Autonomous Lab Robotics | AI-driven drug discovery, Therapeutic program development, Biological and chemical research tools, Disease modeling and target identification, Generative AI software solutions |
| Target Customers | ||
| Target Customers | Pharmaceutical Companies, Biotech Firms, Academic Institutions, Medicinal and Computational Chemists, Drug Discovery Teams | Pharmaceutical companies, Biotech firms, Medical researchers, Healthcare institutions, Academic research bodies |
| Taxonomy | ||
| Taxonomy | Drug Design, Medicinal Chemistry, Generative AI, Chemoinformatics, Robotics Automation, SaaS Software, Molecular Modeling, Oncology, Retrosynthesis, Protein-Protein Interactions, RNA-Protein Interactions, Synthesis Automation, Pharmaceutical R&D, Lead Optimization | Clinical Stage Biotech, Generative AI, AI Drug Discovery, Deep Generative Models, Reinforcement Learning, Novel Molecular Structures, Cancer Treatment, Aging-related Diseases, Neuroscience, Biologics, Digital Medicine, Nutraceuticals, Bioinformatics, Generative Adversarial Networks, Internal Drug Programs |
| Website | ||
| Website | iktos.ai | insilico.com |
About iktos
Iktos, founded in 2016 and headquartered in France, stands out as a leader in the convergence of AI and biotechnology for drug discovery. Its slogan, "Artificial intelligence for new drug design," encapsulates its mission to leverage cutting-edge technologies for medicinal chemistry. The company's...
About Insilico Medicine
Insilico Medicine is a clinical stage biotech firm utilizing cutting-edge AI technology to streamline drug discovery processes. Founded in 2014, the company is headquartered in the United States and operates at the intersection of AI, biotechnology, health care, and pharmaceuticals. The company's i...
We will tell you when either one moves
BounceWatch watches iktos and Insilico Medicine for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at iktos and Insilico Medicine — by email.
Frequently Asked Questions
Compare iktos with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at iktos on 20 Sep 2026, and Insilico Medicine on 21 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
